SINGLE DOSE PARALLEL COMPARATIVE BIOAVAILABILITY STUDY OF TRIAMCINOLONE
HEXACETONIDE FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF A SINGLE DOSE INJECTION
OF TRIAMCINOLONE HEXACETONIDE (20 MG/ML) OR OF THE COMBINATION OF
TRIAMCINOLONE HEXACETONIDE (18 MG/4 ML) AND CROSS-LINKED HYALURONIC ACID
VISCOSUPPLEMENT IN MALE AND FEMALE PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
- Registry ID
- 2612-06
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- ANIKA THERAPEUTICS INC
- Start date
- 2025-10-08
- Last update
- 2025-08-29
Conditions
- OSTEOARTHRITIS
- OSTEOARTHRITIS OF THE KNEE
Related clinical trials
View on source registry